SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
SCHEDULE 13G/A
(Rule 13d-102)
----------------
Amendment No. 2
INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b), (c)
AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
ELITE PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON STOCK, $0.01 PAR VALUE PER SHARE
(Title of Class of Securities)
28659T200
(CUSIP Number)
December 31, 2008
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
-----------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes)
Schedule 13G/A
CUSIP No. 28659T200 PAGE 2 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Partners
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
309 Series C 8% Preferred Stock convertible into
133,190 Common Shares, Warrants exercisable
into 39,956 Common Shares and 81,300 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
309 Series C 8% Preferred Stock convertible into
133,190 Common Shares, Warrants exercisable
into 39,956 Common Shares and 81,300 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
309 Series C 8% Preferred Stock convertible into 133,190
Common Shares, Warrants exercisable into 39,956 Common
Shares and 81,300 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.8%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 3 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Institutional Partners, L.P.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
560 Series C 8% Preferred Stock convertible into
241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
560 Series C 8% Preferred Stock convertible into
241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
560 Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412 Common
Shares and 147,462 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.4%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 4 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M. H. Davidson & Co.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
40 Series C 8% Preferred Stock convertible into
17,241 Common Shares, Warrants exercisable into
5,172 Common Shares and 10,548 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
40 Series C 8% Preferred Stock convertible into
17,241 Common Shares, Warrants exercisable
into 5,172 Common Shares and 10,548 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
40 Series C 8% Preferred Stock convertible into 17,241 Common
Shares, Warrants exercisable into 5,172 Common Shares
and 10,548 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.1%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 5 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner International, Ltd.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,007 Series C 8% Preferred Stock convertible into
434,052 Common Shares, Warrants exercisable
into 130,213 Common Shares and 265,154 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,007 Series C 8% Preferred Stock convertible into
434,052 Common Shares, Warrants exercisable
into 130,213 Common Shares and 265,154 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,007 Series C 8% Preferred Stock convertible into 434,052 Common
Shares, Warrants exercisable into 130,213 Common Shares and
265,154 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
2.5%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
CO
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 6 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Serena Limited
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
0
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
0
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
0
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.0%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
CO
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 7 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Healthcare Fund LP
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
2,449 Series C 8% Preferred Stock convertible into 1,055,603
Common Shares, Warrants exercisable into 316,680
Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
6.0%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 8 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner
Healthcare International Ltd.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
3,602 Series C 8% Preferred Stock convertible into 1,552,586
Common Shares, Warrants exercisable into 465,775
Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
8.8%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
CO
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 9 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MHD Management Co.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
309 Series C 8% Preferred Stock convertible into
133,190 Common Shares, Warrants exercisable
into 39,956 Common Shares and 81,300 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
309 Series C 8% Preferred Stock convertible into
133,190 Common Shares, Warrants exercisable
into 39,956 Common Shares and 81,300 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
309 Series C 8% Preferred Stock convertible into 133,190
Common Shares, Warrants exercisable into 39,956 Common
Shares and 81,300 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.8%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 10 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Advisers Inc.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
560 Series C 8% Preferred Stock convertible into
241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
560 Series C 8% Preferred Stock convertible into
241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
560 Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412 Common
Shares and 147,462 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.4%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IA
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 11 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner International Advisors, L.L.C.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,007 Series C 8% Preferred Stock convertible into
434,052 Common Shares, Warrants exercisable
into 130,213 Common Shares and 265,154 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,007 Series C 8% Preferred Stock convertible into
434,052 Common Shares, Warrants exercisable
into 130,213 Common Shares and 265,154 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,007 Series C 8% Preferred Stock convertible into 434,052
Common Shares, Warrants exercisable into 130,213
Common Shares and 265,154 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
2.5%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
OO
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 12 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DK Group LLC
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
2,449 Series C 8% Preferred Stock convertible into 1,055,603
Common Shares, Warrants exercisable into 316,680
Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
6.0%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
OO
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 13 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DK Management Partners LP
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
OWNED BY _____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
3,602 Series C 8% Preferred Stock convertible into 1,552,586
Common Shares, Warrants exercisable into 465,775
Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
8.8%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 14 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DK Stillwater GP LLC
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
3,602 Series C 8% Preferred Stock convertible into 1,552,586
Common Shares, Warrants exercisable into 465,775
Common Shares and 954,832 Common Shares
______________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
8.8%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
OO
------------------------------------------------------------------------------
Schedule 13G/A
CUSIP No. 28659T200 PAGE 15 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas L. Kempner, Jr.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(1)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(1) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 16 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Marvin H. Davidson
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(2)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(2) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 17 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stephen M. Dowicz
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(3)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(3) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 18 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Scott E. Davidson
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(4)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(4) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 19 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Michael J. Leffell
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH 7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(5)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(5) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 20 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Timothy I. Levart
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom & United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(6)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(6) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 21 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert J. Brivio, Jr.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(7)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(7) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 22 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Eric P. Epstein
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(8)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(8) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 23 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Anthony A. Yoseloff
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(9)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(9) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 24 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Avram Z. Friedman
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(10)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(10) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 25 OF 47
------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Conor Bastable
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(11)
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
---------------------
(11) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 26 OF 47
------------------------------------------------------------------------------
ITEM 1(a). NAME OF ISSUER:
Elite Pharmaceuticals, Inc. (the "Company")
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
165 Ludlow Avenue
Northvale, NJ 07647
ITEM 2(a). NAME OF PERSON FILING:
This Statement is filed by each of the entities and persons listed below,
all of whom together are referred to herein as the "Reporting Persons":
(i) Davidson Kempner Partners, a New York limited
partnership ("DKP");
(ii) Davidson Kempner Institutional Partners, L.P., a
Delaware limited partnership ("DKIP");
(iii) M. H. Davidson & Co., a New York limited partnership
("CO");
(iv) Davidson Kempner International, Ltd., a British
Virgin Islands corporation ("DKIL");
(v) Serena Limited, a Cayman Islands corporation ("Serena");
(vi) Davidson Kempner Healthcare Fund LP, a Delaware
limited partnership ("DKHF");
(vii) Davidson Kempner Healthcare International Ltd., a
Cayman Islands corporation ("DKHI");
(viii) MHD Management Co., a New York limited partnership
and the general partner of DKP ("MHD");
(ix) Davidson Kempner Advisers Inc., a New York
corporation and the general partner of DKIP ("DKAI"),
which is registered as an investment adviser with the
U.S. Securities and Exchange Commission;
(x) Davidson Kempner International Advisors, L.L.C., a
Delaware limited liability company and the manager of
DKIL and Serena ("DKIA");
(xi) DK Group LLC, a Delaware limited liability company
and the general partner of DKHF ("DKG");
(xii) DK Management Partners LP, a Delaware limited
partnership and the investment manager of DKHI
("DKMP");
Schedule 13G/A
CUSIP No. 28659T200 PAGE 27 OF 47
(xiii) DK Stillwater GP LLC, a Delaware limited liability
company and the general partner of DKMP ("DKS"); and
(xiv) Messrs. Thomas L. Kempner, Jr., Marvin H. Davidson,
Stephen M. Dowicz, Scott E. Davidson, Michael J. Leffell,
Timothy I. Levart, Robert J. Brivio, Jr., Anthony A.
Yoseloff, Eric P. Epstein, Avram Z. Friedman and Conor
Bastable (collectively, the "Principals"), who are the
general partners of CO and MHD, the sole managing members
of DKIA and DKG and the sole stockholders of DKAI. Messrs.
Thomas L. Kempner, Jr. and Timothy I. Levart are Executive
Managing Member and Deputy Executive Managing Member,
respectively, of DKS. Each of Messrs. Kempner and Levart,
together with Messrs. Marvin H. Davidson, Stephen
M. Dowicz, Scott E. Davidson, Michael J. Leffell, Robert
J. Brivio, Jr., Anthony A. Yoseloff, Eric P. Epstein,
Avram Z. Friedman and Conor Bastable are limited partners
of DKMP.
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE:
The address of the principal business office of each of the Reporting
Persons is c/o Davidson Kempner Partners, 65 East 55th Street, 19th Floor, New
York, New York 10022.
ITEM 2(c). CITIZENSHIP:
(i) DKP - a New York limited partnership
(ii) DKIP - a Delaware limited partnership
(iii) CO - a New York limited partnership
(iv) DKIL - a British Virgin Islands corporation
(v) Serena - a Cayman Islands corporation
(vi) DKHF - a Delaware limited partnership
(vii) DKHI - a Cayman Islands corporation
(viii) MHD - a New York limited partnership
(ix) DKAI - a New York corporation
(x) DKIA - a Delaware limited liability company
(xi) DKG - a Delaware limited liability company
(xii) DKMP - a Delaware limited partnership
(xiii) DKS - a Delaware limited liability company
(xiv) Thomas L. Kempner, Jr. - United States
(xv) Marvin H. Davidson - United States
Schedule 13G/A
CUSIP No. 28659T200 PAGE 28 OF 47
(xvi) Stephen M. Dowicz - United States
(xvii) Scott E. Davidson -United States
(xviii) Michael J. Leffell - United States
(xix) Timothy I. Levart - United Kingdom & United States
(xx) Robert J. Brivio, Jr. - United States
(xxi) Eric P. Epstein - United States
(xxii) Anthony A. Yoseloff - United States
(xxiii) Avram Z. Friedman - United States
(xxiv) Conor Bastable - United States
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
COMMON STOCK, $0.01 PAR VALUE PER SHARE
ITEM 2(e). CUSIP NUMBER:
28659T200
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO 13d-1(b) OR 13d-2(b) OR (c),
CHECK WHETHER THE PERSON FILING IS A:
(a)[ ] Broker or dealer registered under Section 15
of the Act;
(b)[ ] Bank as defined in Section 3(a)(6) of the
Act;
(c)[ ] Insurance Company as defined in Section
3(a)(19) of the Act;
(d)[ ] Investment Company registered under Section 8
of the Investment Company Act of 1940;
(e)[ ] Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940: see Rule 13d-1(b)(1)(ii)
E);
(f)[ ] Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee
Retirement Income Security Act of 1974 or
Endowment Fund; see Rule 13d-1(b)(1)(ii)(F);
(g)[ ] Parent Holding Company, in accordance with
Rule 13d-1(b)(ii)(G);
(h)[ ] Savings Associations as defined in Section
3(b) of the Federal Deposit Insurance Act;
Schedule 13G/A
CUSIP No. 28659T200 PAGE 29 OF 47
(i)[ ] Church Plan that is excluded from the
definition of an investment company under Section
3(c)(14) of the Investment Company Act of 1940;
(j)[ ] Group, in accordance with Rule
13d-1(b)(1)(ii)(J).
ITEM 4. OWNERSHIP.
Subject to the Ownership Limitation (as defined below), the Principals may
be deemed to beneficially own an aggregate of 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable into 1,030,208
Common Shares and 2,108,249 Common Shares as a result of their voting and
dispositive power over the 7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into 1,030,208 Common Shares and
2,108,249 Common Shares beneficially owned by DKP, DKIP, DKIL, CO, DKHF and
DKHI.
DKIA may be deemed to beneficially own the 1,007 Series C 8% Preferred
Stock convertible into 434,052 Common Shares, Warrants exercisable into 130,213
Common Shares and 265,154 Common Shares beneficially owned by DKIL as a result
of its voting and dispositive power over those shares. DKAI may be deemed to
beneficially own the 560 Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412 Common Shares and 147,462 Common
Shares owned by DKIP as a result of its voting and dispositive power over those
shares. MHD may be deemed to beneficially own the 309 Series C 8% Preferred
Stock convertible into 133,190 Common Shares, Warrants exercisable into 39,956
Common Shares and 81,300 Common Shares beneficially owned by DKP as a result of
its voting and dispositive power over those shares. DKG may be deemed to
beneficially own the 2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable into 316,680 Common Shares and
648,953 Common Shares beneficially owned by DKHF as a result of its voting and
dispositive power over those shares. DKMP and DKS may be deemed to beneficially
own the 3,602 Series C 8% Preferred Stock convertible into 1,552,586 Common
Shares, Warrants exercisable into Common Shares and 954,832 Common Shares
beneficially owned by DKHI as a result of their voting and dispositive power
over those shares.
As set forth in the Certificate of Designation of Preferences, Rights and
Limitations of Series C 8% Convertible Preferred Stock and each Common Stock
Purchase Warrant held by the Reporting Persons, respectively, the number of
Common Shares into which the Preferred Stock are convertible and the Warrants
are exercisable is limited to that number of Common Shares which would result in
the Reporting Persons having aggregate beneficial ownership of not more than
9.99% of the total issued and outstanding shares of Common Shares (the
"Ownership Limitation").
A. DKP
(a) Amount beneficially owned: 309 Series C 8% Preferred Stock
convertible into 133,190 Common Shares, Warrants exercisable into
39,956 Common Shares and 81,300 Common Shares
(b) Percent of class: 0.8%
(c) Number of shares as to which such person has:
Schedule 13G/A
CUSIP No. 28659T200 PAGE 30 OF 47
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 309
Series C 8% Preferred Stock convertible into 133,190
Common Shares, Warrants exercisable into 39,956 Common
Shares and 81,300 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
309 Series C 8% Preferred Stock convertible into 133,190
Common Shares, Warrants exercisable into 39,956 Common
Shares and 81,300 Common Shares
B. DKIP
(a) Amount beneficially owned: 560 Series C 8% Preferred Stock
convertible into 241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
(b) Percent of class: 1.4%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 560
Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412 Common
Shares and 147,462 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
560 Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412 Common
Shares and 147,462 Common Shares
C. CO
(a) Amount beneficially owned: 40 Series C 8% Preferred Stock
convertible into 17,241 Common Shares, Warrants exercisable
into 5,172 Common Shares and 10,548 Common Shares
(b) Percent of class: 0.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 40 Series
C 8% Preferred Stock convertible into 17,241 Common
Shares, Warrants exercisable into 5,172 Common Shares
and 10,548 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
Schedule 13G/A
CUSIP No. 28659T200 PAGE 31 OF 47
(iv) shared power to dispose or to direct the disposition:
40 Series C 8% Preferred Stock convertible into
17,241 Common Shares, Warrants exercisable into
5,172 Common Shares and 10,548 Common Shares
D. DKIL
(a) Amount beneficially owned: 1,007 Series C 8% Preferred Stock
convertible into 434,052 Common Shares, Warrants exercisable into
130,213 Common Shares and 265,154 Common Shares
(b) Percent of class: 2.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 1,007 Series
C 8% Preferred Stock convertible into 434,052 Common Shares,
Warrants exercisable into 130,213 Common Shares and 265,154
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition: 1,007
Series C 8% Preferred Stock convertible into 434,052 Common
Shares, Warrants exercisable into 130,213 Common Shares and
265,154 Common Shares
E. Serena
(a) Amount beneficially owned: 0
(b) Percent of class: 0.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition: 0
F. DKHF
(a) Amount beneficially owned: 2,449 Series C 8% Preferred Stock
convertible into 1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
(b) Percent of class: 6.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 2,449
Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
Schedule 13G/A
CUSIP No. 28659T200 PAGE 32 OF 47
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
G. DKHI
(a) Amount beneficially owned: 3,602 Series C 8% Preferred Stock
convertible into 1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
(b) Percent of class: 8.8%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 3,602
Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
H. MHD
(a) Amount beneficially owned: 309 Series C 8% Preferred Stock
convertible into 133,190 Common Shares, Warrants exercisable
into 39,956 Common Shares and 81,300 Common Shares
(b) Percent of class: 0.8%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 309
Series C 8% Preferred Stock convertible into 133,190
Common Shares, Warrants exercisable into 39,956
Common Shares and 81,300 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
309 Series C 8% Preferred Stock convertible into
133,190 Common Shares, Warrants exercisable
into 39,956 Common Shares and 81,300 Common Shares
I. DKAI
(a) Amount beneficially owned: 560 Series C 8% Preferred Stock
convertible into 241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
(b) Percent of class: 1.4%
(c) Number of shares as to which such person has:
Schedule 13G/A
CUSIP No. 28659T200 PAGE 33 OF 47
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 560
Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412
Common Shares and 147,462 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
560 Series C 8% Preferred Stock convertible into
241,379 Common Shares, Warrants exercisable
into 72,412 Common Shares and 147,462 Common Shares
J. DKIA
(a) Amount beneficially owned: 1,007 Series C 8% Preferred Stock
convertible into 434,052 Common Shares, Warrants exercisable
into 130,213 Common Shares and 265,154 Common Shares
(b) Percent of class: 2.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 1,007
Series C 8% Preferred Stock convertible into 434,052
Common Shares, Warrants exercisable into 130,213
Common Shares and 265,154 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
1,007 Series C 8% Preferred Stock convertible into
434,052 Common Shares, Warrants exercisable
into 130,213 Common Shares and 265,154 Common Shares
K. DKG
(a) Amount beneficially owned: 2,449 Series C 8% Preferred Stock
convertible into 1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
(b) Percent of class: 6.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 2,449
Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
Schedule 13G/A
CUSIP No. 28659T200 PAGE 34 OF 47
(iv) shared power to dispose or to direct the disposition:
2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable
into 316,680 Common Shares and 648,953 Common Shares
L. DKMP
(a) Amount beneficially owned: 3,602 Series C 8% Preferred Stock
convertible into 1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
(b) Percent of class: 8.8%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 3,602
Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable into
465,775 Common Shares and 954,832 Common Shares
M. DKS
(a) Amount beneficially owned: 3,602 Series C 8% Preferred Stock
convertible into 1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
(b) Percent of class: 8.8%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 3,602
Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
3,602 Series C 8% Preferred Stock convertible into
1,552,586 Common Shares, Warrants exercisable
into 465,775 Common Shares and 954,832 Common Shares
Schedule 13G/A
CUSIP No. 28659T200 PAGE 35 OF 47
N. Thomas L. Kempner, Jr.
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(12)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
O. Marvin H. Davidson
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(13)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
---------------------
(12) Subject to the Ownership Limitation (as defined herein).
(13) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 36 OF 47
P. Stephen M. Dowicz
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(14)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
Q. Scott E. Davidson
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(15)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
---------------------
(14) Subject to the Ownership Limitation (as defined herein).
(15) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 37 OF 47
R. Michael J. Leffell
(a) Amount beneficially owned. 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(16)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
S. Timothy I. Levart
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(17)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
---------------------
(16) Subject to the Ownership Limitation (as defined herein).
(17) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 38 OF 47
T. Robert J. Brivio, Jr.
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(18)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
U. Eric P. Epstein
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(19)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
---------------------
(18) Subject to the Ownership Limitation (as defined herein).
(19) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 39 OF 47
V. Anthony A. Yoseloff
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(20)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
W. Avram Z. Friedman
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(21)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
---------------------
(20) Subject to the Ownership Limitation (as defined herein).
(21) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 40 OF 47
X. Conor Bastable
(a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable
into 1,030,208 Common Shares and 2,108,249 Common Shares
(b) Percent of class: 9.9%(21)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 7,967
Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into
1,030,208 Common Shares and 2,108,249 Common Shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
The partners, members or stockholders of each of the Reporting Persons,
including the Principals, have the right to participate in the receipt of
dividends from, or proceeds from the sale of, the securities held for the
account of such Reporting Person in accordance with their ownership interests in
such Reporting Person. The Reporting Persons disclaim all beneficial ownership
as affiliates of a registered investment adviser, and, in any case, disclaim
beneficial ownership except as to the extent of their pecuniary interest in the
shares. The Reporting Persons have elected to file Schedule 13G although such
filing may not be required under the Act.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
See Item 4.
---------------------
(22) Subject to the Ownership Limitation (as defined herein).
Schedule 13G/A
CUSIP No. 28659T200 PAGE 41 OF 47
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION. (if filing pursuant to Rule 13d-1(c))
Each of the Reporting Persons hereby makes the following certification:
By signing below we certify that, to the best of our knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
Schedule 13G/A
CUSIP No. 28659T200 PAGE 42 OF 47
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
DATED: February 17, 2009 DAVIDSON KEMPNER PARTNERS
By: MHD Management Co.,
its General Partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INSTITUTIONAL
PARTNERS, L.P.
By: Davidson Kempner Advisers Inc.,
its General Partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: President
M.H. DAVIDSON & CO.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INTERNATIONAL, LTD.
By: Davidson Kempner International
Advisors, L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
SERENA LIMITED
By: Davidson Kempner International
Advisors, L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G/A
CUSIP No. 28659T200 PAGE 43 OF 47
DAVIDSON KEMPNER HEALTHCARE FUND LP
By: DK Group LLC,
its General Partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DAVIDSON KEMPNER HEALTHCARE
INTERNATIONAL LTD.
By: DK Management Partners LP,
its Investment Manager
By: DK Stillwater GP LLC, its
general partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
MHD MANAGEMENT CO.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER ADVISERS INC.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: President
DAVIDSON KEMPNER INTERNATIONAL
ADVISORS, L.L.C.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK GROUP LLC
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G/A
CUSIP No. 28659T200 PAGE 44 OF 47
DK MANAGEMENT PARTNERS LP
By: DK Stillwater GP LLC, its
general partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK STILLWATER GP LLC
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
/s/ Thomas L. Kempner, Jr.
--------------------------
Thomas L. Kempner, Jr.
/s/ Marvin H. Davidson
--------------------------
Marvin H. Davidson
/s/ Stephen M. Dowicz
--------------------------
Stephen M. Dowicz
/s/ Scott E. Davidson
--------------------------
Scott E. Davidson
/s/ Michael J. Leffell
--------------------------
Michael J. Leffell
/s/ Timothy I. Levart
--------------------------
Timothy I. Levart
/s/ Robert J. Brivio, Jr.
-------------------------
Robert J. Brivio, Jr.
/s/ Eric P. Epstein
-------------------------
Eric P. Epstein
/s/ Anthony A. Yoseloff
-------------------------
Anthony A. Yoseloff
/s/ Avram Z. Friedman
-------------------------
Avram Z. Friedman
/s/ Conor Bastable
-------------------------
Conor Bastable
Schedule 13G/A
CUSIP No. 28659T200 PAGE 45 OF 47
EXHIBIT 1
JOINT ACQUISITION STATEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13G is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13G, shall be filed on
behalf of each of the undersigned without the necessity of filing additional
joint acquisition statements. The undersigned acknowledge that each shall be
responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained therein, but
shall not be responsible for the completeness and accuracy of the information
concerning the others, except to the extent that he or it knows or has reason to
believe that such information is inaccurate.
DATED: February 17, 2009 DAVIDSON KEMPNER PARTNERS
By: MHD Management Co.,
its General Partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INSTITUTIONAL PARTNERS,
L.P.
By: Davidson Kempner Advisers Inc.,
its General Partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: President
M.H. DAVIDSON & CO.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INTERNATIONAL, LTD.
By: Davidson Kempner International
Advisors, L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G/A
CUSIP No. 28659T200 PAGE 46 OF 47
SERENA LIMITED
By: Davidson Kempner International
Advisors, L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DAVIDSON KEMPNER HEALTHCARE FUND LP
By: DK Group LLC,
its General Partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DAVIDSON KEMPNER HEALTHCARE
INTERNATIONAL LTD.
By: DK Management Partners LP,
its Investment Manager
By: DK Stillwater GP LLC, its general
partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
MHD MANAGEMENT CO.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER ADVISERS INC.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: President
DAVIDSON KEMPNER INTERNATIONAL ADVISORS,
L.L.C.
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G/A
CUSIP No. 28659T200 PAGE 47 OF 47
DK GROUP LLC
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK MANAGEMENT PARTNERS LP
By: DK Stillwater GP LLC, its general
partner
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK STILLWATER GP LLC
/s/ Thomas L. Kempner, Jr.
--------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
/s/ Thomas L. Kempner, Jr.
--------------------------
Thomas L. Kempner, Jr.
/s/ Marvin H. Davidson
--------------------------
Marvin H. Davidson
/s/ Stephen M. Dowicz
--------------------------
Stephen M. Dowicz
/s/ Scott E. Davidson
--------------------------
Scott E. Davidson
/s/ Michael J. Leffell
--------------------------
Michael J. Leffell
/s/ Timothy I. Levart
--------------------------
Timothy I. Levart
/s/ Robert J. Brivio, Jr.
-------------------------
Robert J. Brivio, Jr.
/s/ Eric P. Epstein
--------------------------
Eric P. Epstein
/s/ Anthony A. Yoseloff
--------------------------
Anthony A. Yoseloff
/s/ Avram Z. Friedman
--------------------------
Avram Z. Friedman
/s/ Conor Bastable
--------------------------
Conor Bastable